Federated Hermes’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Federated Hermes’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,809	Closed	-$7K	–	2454
2020 Q1	$7K	Buy	1,809 +104	+6%	+$448	﹤0.01%	1905
2019 Q4	$9K	Sell	1,705 -113	-6%	-$598	﹤0.01%	1915
2019 Q3	$9K	Buy	+1,818	New	+$9.07K	﹤0.01%	1905
2019 Q1	–	Sell	-3,451,447	Closed	-$14.5M	–	2269
2018 Q4	$14.5M	Sell	3,451,447 -2,967,153	-46%	-$15.1M	0.04%	382
2018 Q3	$40.2M	Sell	6,418,600 -577,455	-8%	-$4.44M	0.09%	229
2018 Q2	$56.2M	Sell	6,996,055 -3,191,708	-31%	-$24.4M	0.16%	120
2018 Q1	$76M	Hold	10,187,763	–	–	0.22%	91
2017 Q4	$60.6M	Sell	10,187,763 -429,700	-4%	-$2.61M	0.17%	110
2017 Q3	$78.1M	Sell	10,617,463 -293,297	-3%	-$1.86M	0.22%	93
2017 Q2	$74.1M	Sell	10,910,760 -1,379,570	-11%	-$10.2M	0.21%	92
2017 Q1	$116M	Buy	12,290,330 +3,130	+0%	+$31.2K	0.33%	53
2016 Q4	$106M	Sell	12,287,200 -282,490	-2%	-$2.09M	0.32%	52
2016 Q3	$79.6M	Sell	12,569,690 -595,000	-5%	-$3.6M	0.23%	80
2016 Q2	$55.6M	Sell	13,164,690 -343,600	-3%	-$1.66M	0.16%	110
2016 Q1	$58.9M	Hold	13,508,290	–	–	0.18%	99
2015 Q4	$82.8M	Hold	13,508,290	–	–	0.26%	78
2015 Q3	$77.3M	Hold	13,508,290	–	–	0.25%	73
2015 Q2	$101M	Hold	13,508,290	–	–	0.3%	60
2015 Q1	$80.8M	Hold	13,508,290	–	–	0.25%	80
2014 Q4	$102M	Hold	13,508,290	–	–	0.32%	63
2014 Q3	$70.1M	Hold	13,508,290	–	–	0.23%	90
2014 Q2	$58.2M	Sell	13,508,290 -41,500	-0.3%	-$158K	0.18%	109
2014 Q1	$55.4M	Buy	13,549,790 +1,000,000	+8%	+$5.11M	0.19%	111
2013 Q4	$66.9M	Hold	12,549,790	–	–	0.23%	87
2013 Q3	$63.1M	Hold	12,549,790	–	–	0.24%	87
2013 Q2	$56M	Buy	+12,549,790	New	+$56.3M	0.22%	100

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Federated Hermes's PGNX Position: Q2 2020 in Review

Federated Hermes sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 1,809 shares — an estimated $7K sold.

Federated Hermes first reported a position in PGNX in Q2 2013 and held it in 26 quarters. The position peaked at $116M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Federated Hermes reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Federated Hermes sold 1,809 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $7K.
Federated Hermes first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 26 quarters.
Federated Hermes's Progenics Pharmaceuticals Inc position peaked at $116M in Q1 2017.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.